In relation to mechanisms involved in functional recovery of manual dexterity from cervical cord injury or from motor cortical injury, our goal was to determine whether the movements that characterize post-lesion functional recovery are comparable to original movement patterns or do monkeys adopt distinct strategies to compensate the deficits depending on the type of lesion? To this aim, data derived from earlier studies, using a skilled finger task (the modified Brinkman board from which pellets are retrieved from vertical or horizontal slots), in spinal cord and motor cortex injured monkeys were analyzed and compared. Twelve adult macaque monkeys were subjected to a hemi-section of the cervical cord (n = 6) or to a unilateral excitotoxic lesion of the hand representation in the primary motor cortex (n = 6). In addition, in each subgroup, one half of monkeys (n = 3) were treated for 30 days with a function blocking antibody against the neurite growth inhibitory protein Nogo-A, while the other half (n = 3) represented control animals. The motor deficits, and the extent and time course of functional recovery were assessed. For some of the parameters investigated (wrist angle for horizontal slots and movement types distribution for vertical slots after cervical injury; movement types distribution for horizontal slots after motor cortex lesion), post-lesion restoration of the original movement patterns (“true” recovery) led to a quantitatively better functional recovery. In the motor cortex lesion groups, pharmacological reversible inactivation experiments showed that the peri-lesion territory of the primary motor cortex or re-arranged, spared domain of the lesion zone, played a major role in the functional recovery, together with the ipsilesional intact premotor cortex.
Remifentanil is routinely administered in human neurosurgery whilst its use in non-human primates is not described. Here we described a new remifentanil-propofol total intravenous anesthesia (TIVA) for macaque neurosurgery and we compared it retrospectively to fentanyl-propofol anesthesia. Twelve anesthesias were performed (F=6; R=6). After premedication, anesthesia was induced with 3 mcg/kg fentanyl (F) or 3 mcg/kg remifentanil (R) intravenously (IV) and maintained through propofol and fentanyl [0.17 ± 0.01 mcg/kg/min after induction and 0.13 ± 0.01 mcg/kg/min during maintenance] or remifentanil [0.1 ± 0.02 mcg/kg/min after induction and 0.16 ± 0.05 mcg/kg/min during maintenance] constant-rate-infusion (CRI), respectively. Tracheal intubation in R was characterized by apnea, absence of laryngeal reaction, and cough compared to F. The mean propofol rate administered in F [0.3 ± 0.1 at start to 0.2± 0.1 mg/kg/min for maintenance] was significantly higher than in R [0.17 ± 0.1 at start to 0.16 ± 0.01 mg/kg/min for maintenance].The cardiovascular and respiratory parameters did not differ significantly between the two groups. Extubation time was shorter in R compared to F [8 (6– 10) and 18 (14– 22) minutes respectively]. Finally, the new remifentanil-propofol TIVA proved to be a beneficial refinement for macaque neurosurgery, providing smoother intubation, cardiovascular stability, lower propofol requirements and faster recovery.